Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nick P. D’Amato
Observed name:
Nick P D’Amato
Institution:
Vaxart (United States)
Observed institution:
Vaxart (United States)
ORCID:
0009-0009-7055-1215
Observed ORCID:
0009-0009-7055-1215
OpenAlex ID:
A5117540244
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study
2025
·
Becca A. Flitter
, Joshua Gillard
, et al.
·
Science Translational Medicine
·
23
Transfer of breast milk IgA to infants after oral bivalent norovirus vaccination of post-partum women
2026
·
Molly R. Braun
, Lam-Quynh Nguyen
, et al.
·
npj Vaccines
·
2
PDF
175. An Open-Label Phase 1 Clinical Trial Demonstrating Improved Immune Responses to Norovirus Strains GI.1 and GII.4 from a Second Generation Oral Bivalent Vaccine Candidate
2026
·
Nicholas J Bennett
, Becca A Flitter
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
3
Citation count:
25
H-index:
2
I10-index:
1
Year
Topic
Type
